Sechenov School
Home › Pathology › Plasma Inflammatory Mediators

Plasma Inflammatory Mediators

For medical students2 min readUpdated 2026-10-10

Plasma inflammatory mediators are components of three interconnected blood systems that circulate as inactive precursors and are recruited into the pathological process via a cascade mechanism. Their main objective is to delineate the site of injury, immobilize the pathogenic factor, and ensure its destruction.

OriginSynthesized in the liver (by hepatocytes), monocytes, and leukocytes, and present in blood plasma.
MechanismOperate via a cascade mechanism: the activation of one component triggers the activation of the next.
Pain MediatorBradykinin (a component of the kinin system) is responsible for generating the sensation of pain at the lesion site.
Hageman FactorLinks the blood coagulation system with the inflammatory response by initiating coagulation.

General Characteristics and Dynamics of the Process

Plasma inflammatory mediators represent a complex of biologically active substances. They circulate in the bloodstream as inactive precursors, are activated by specific triggers, and are strictly controlled by inhibitors. The primary feature of this group is their function via a cascade mechanism, where the activation of a single molecule triggers a chain reaction of subsequent components.

In the dynamics of the inflammatory process, plasma factors do not come into play immediately. The strict sequence is as follows: first, cellular mediators are released in the tissues, provoking a primary vascular response, and only then are plasma mediators recruited. This leads to a massive influx of exudate into the lesion.

The global goal of all these reactions boils down to three tasks: reliable demarcation of the site of injury, immobilization of the pathogenic factor within it, and its eventual destruction.

Basic Effects of Plasma Systems:

Kinin System

The components of this system are derived from blood plasma and other body fluids. Key representatives include kinins (specifically kallidin and bradykinin), as well as the enzyme kallikrein.

Complement System

The complement system consists of specific plasma proteins synthesized by hepatocytes, monocytes, and leukocytes. The primary function of complement is bactericidal activity and cytolysis, i.e., the direct destruction of bacteria and cells (including the lysis of damaged host tissues).

Key components of the system, particularly the C3b and C5b fractions, elicit a wide range of effects:

Hemostatic System and Hageman Factor

The components of the blood coagulation system are produced in the liver. During inflammation, the hemostatic system becomes an integral component of the reaction rather than merely a mechanism for arresting hemorrhage.

The central link here is Factor XII (Hageman factor). It initiates blood clotting and acts as a potent inflammatory mediator:

As a result of hemostatic system activity, microthroμβι form, physically blocking the spread of infection. Subsequently, fibrin clot lysis is triggered, leukocyte adhesion is enhanced, and fibroblast proliferation begins, preparing the tissue for regeneration.

Mnemonic

The three systems of plasma mediators can be easily remembered using the rule of three "K"s: Kinins (pain and vessels), Komplement/Complement (lysis and opsonization), Koagulation/Coagulation (thrombi and Hageman factor).

Frequently asked questions

What components make up the plasma kinin system?

The plasma kinin system consists of precursor proteins, enzymes, and active peptides.

  • Kininogen — a high-molecular-weight precursor protein produced in the liver and circulating in the blood.
  • Prekallikrein — an inactive precursor converted to its active form by blood clotting factor XII.
  • Kallikrein — a trypsin-like serine peptidase that cleaves kinins from kininogen.
  • Kinins (bradykinin, kallidin) — active peptides that cause arteriolar dilation, pain sensation, and increased microvascular permeability.
What are the pathways of complement system activation?

There are three main pathways of complement activation:

  • Classical pathway;
  • Lectin pathway;
  • Alternative pathway.

All three pathways converge at the stage of enzymatic complex formation — convertases — and culminate in the assembly of the membrane attack complex on the target cell surface.

Which inhibitors control the activity of plasma inflammatory mediators?

The activity of plasma inflammatory mediators is controlled by specific inhibitors of the complement, hemostasis, and fibrinolytic systems.

  • C1 inhibitor (C1INH) — suppresses the esterase activity of classical and lectin pathway factors.
  • Factor H (CFH) — the main regulatory protein of the alternative complement pathway.
  • CD55 (DAF) — a glycoprotein regulating C3 convertase activity.
  • CD59 (MIRL) — an inhibitor blocking membrane attack complex assembly.
  • Antithrombin III — inhibits thrombin and blood coagulation factors.
  • Plasmin inhibitors — limit the action of plasmin in the fibrinolytic system.
Besides Hageman factor, what other blood coagulation factors act as inflammatory mediators?

In addition to Hageman factor, thrombin acts as an important inflammatory mediator derived from the blood clotting system.

  • Thrombin — an enzyme generated during the activation of the hemostatic system. At the inflammatory site, it increases vascular endothelial permeability, stimulates the further release of biologically active substances from mast cells, and promotes the generation of the pro-inflammatory complement component C5a (anaphylatoxin).
In what sequence are mediators recruited into the inflammatory process?

Inflammation always begins with the release of cellular mediators, which trigger the primary vascular response. Only after this are plasma mediators activated, ensuring the efflux of exudate into the tissues.

What is the role of the complement system in inflammation?

Complement is responsible for cytolysis (destruction of bacteria and damaged host cells), opsonization of pathogens for phagocytic uptake, and leukocyte chemotaxis.

How does the hemostatic system help combat the injurious factor?

It forms microthrombi that physically demarcate the inflammatory lesion and prevent the pathogen from spreading. Later, fibrin lysis and fibroblast proliferation occur to promote healing.

Which substance causes pain during inflammation?

The primary pain mediator of plasma origin is bradykinin, which belongs to the kallikrein-kinin system.

Go deeper

More topics in Pathology

Pulpitis: Pathology, Classification and Clinical FormsInternational Classification of DiseasesBirth Injury: Types, Pathophysiology and Clinical PresentationCarbohydrate DystrophiesMacroscopic Appearance of NecrosisStages of Compensatory and Adaptive ProcessesNatural Killer CellsRheumatic GranulomaLocal Venous HyperemiaEtiology and Pathogenesis of Essential HypertensionRapidly Progressive GlomerulonephritisPulmonary AtelectasisPathology →